Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Whole-exome sequencing of Finnish hereditary breast cancer families
Kirsi Määttä, Tommi Rantapero, Anna Lindström, et al.
European Journal of Human Genetics (2016) Vol. 25, Iss. 1, pp. 85-93
Open Access | Times Cited: 21

Showing 21 citing articles:

The impact of rare and low-frequency genetic variants in common disease
Lorenzo Bomba, Klaudia Walter, Nicole Soranzo
Genome biology (2017) Vol. 18, Iss. 1
Open Access | Times Cited: 333
The association between ATM variants and risk of breast cancer: a systematic review and meta-analysis
Masoumeh Moslemi, Yousef Moradi, Hojat Dehghanbanadaki, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 51
High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features
Juan Manuel Rosa-Rosa, Tamara Caniego-Casas, Susanna Leskelä, et al.
Cancers (2019) Vol. 11, Iss. 1, pp. 74-74
Open Access | Times Cited: 42
Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer
Veronica Zelli, Chiara Compagnoni, Katia Cannita, et al.
High-Throughput (2020) Vol. 9, Iss. 1, pp. 1-1
Open Access | Times Cited: 29
ATM in breast and brain tumors: a comprehensive review
Asghari Estiar Mehrdad, Parvin Mehdipour
Cancer Biology and Medicine (2018) Vol. 15, Iss. 3, pp. 210-210
Open Access | Times Cited: 26
Integrating Somatic Mutations for Breast Cancer Survival Prediction Using Machine Learning Methods
Zongzhen He, Junying Zhang, Xiguo Yuan, et al.
Frontiers in Genetics (2021) Vol. 11
Open Access | Times Cited: 18
A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer
Melissa Rotunno, Rolando Barajas, Mindy Clyne, et al.
Cancer Epidemiology Biomarkers & Prevention (2020) Vol. 29, Iss. 8, pp. 1519-1534
Open Access | Times Cited: 18
RRM2B Is Frequently Amplified Across Multiple Tumor Types: Implications for DNA Repair, Cellular Survival, and Cancer Therapy
Waleed Iqbal, Elena V. Demidova, Samantha Serrao, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 14
Investigation of the effects of overexpression of jumping translocation breakpoint (JTB) protein in MCF7 cells for potential use as a biomarker in breast cancer.
Madhuri Jayathirtha, Anca-Narcisa Neagu, Danielle Whitham, et al.
PubMed (2022) Vol. 12, Iss. 4, pp. 1784-1823
Closed Access | Times Cited: 9
Evaluation of DNA repair efficiency in autistic children by molecular cytogenetic analysis and transcriptome profiling
Sabry M. Attia, Mohammed A. Al‐Hamamah, Sheikh F. Ahmad, et al.
DNA repair (2019) Vol. 85, pp. 102750-102750
Closed Access | Times Cited: 14
Familial associations of male breast cancer with other cancers
Guoqiao Zheng, Hongyao Yu, Akseli Hemminki, et al.
Breast Cancer Research and Treatment (2017) Vol. 166, Iss. 3, pp. 897-902
Closed Access | Times Cited: 8
Overexpression of RAD50 is the Marker of Poor Prognosis and Drug Resistance in Breast Cancer Patients
Uzma Karamat, Samina Ejaz
Current Cancer Drug Targets (2020) Vol. 21, Iss. 2, pp. 163-176
Closed Access | Times Cited: 7
The NCCN Criterion “Young Age at Onset” Alone is Not an Indicator of Hereditary Breast Cancer in Iranian Population
Elmira Ebrahimi, Erin Sellars, Reza Shirkoohi, et al.
Cancer Prevention Research (2019) Vol. 12, Iss. 11, pp. 763-770
Open Access | Times Cited: 6
The Enduring Importance of Family Health History in the Era of Genomic Medicine and Risk Assessment
Susanne B. Haga, Lori A. Orlando
Personalized Medicine (2020) Vol. 17, Iss. 3, pp. 229-239
Closed Access | Times Cited: 6
Rare Germline Variants in DNA Repair Genes Detected in BRCA-Negative Finnish Patients with Early-Onset Breast Cancer
Viivi Kurkilahti, Venkat Subramaniam Rathinakannan, Erja Nynäs, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2955-2955
Open Access
The compensatory increase of Gli-similar 3 inhibited neuronal apoptosis through regulating Mps one binder kinase activator 1b (MOB1b): a possible strategy for the functional recovery after spinal cord injury
Hongbo Yang, Ying Li, X Li, et al.
EXPERIMENTAL ANIMALS (2023) Vol. 73, Iss. 1, pp. 61-72
Open Access | Times Cited: 1
Genetic Mutations Associated with Hormone-Positive Breast Cancer in a Small Cohort of Ethiopian Women
Alyssa D. Schwartz, Afua Adusei, Solomon Tsegaye, et al.
Annals of Biomedical Engineering (2021) Vol. 49, Iss. 8, pp. 1900-1908
Open Access | Times Cited: 3
Genetic Mutations Associated with Hormone-Positive Breast Cancer in Ethiopian Women
Alyssa D. Schwartz, Afua Adusei, Solomon Tsegaye, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1
Investigation of discordant sibling pairs from hereditary breast cancer families and analysis of a rare PMS1 variant
KK Landry, DJ Seward, JA Dragon, et al.
Cancer Genetics (2021) Vol. 260-261, pp. 30-36
Closed Access | Times Cited: 1
RRM2Bis frequently amplified across multiple tumor types: non-oncogenic addiction and therapeutic opportunities
Waleed Iqbal, Elena V. Demidova, Samantha Serrao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access
Multiple primary malignancies in breast cancer patients. From population study to genetics
Jenny Nyqvist
(2021)
Closed Access
Page 1

Scroll to top